A detailed history of Inspire Trust Co, N.A. transactions in Moderna, Inc. stock. As of the latest transaction made, Inspire Trust Co, N.A. holds 16,525 shares of MRNA stock, worth $694,050. This represents 0.3% of its overall portfolio holdings.

Number of Shares
16,525
Previous 9,525 73.49%
Holding current value
$694,050
Previous $1.13 Billion 2.36%
% of portfolio
0.3%
Previous 0.37%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 02, 2024

BUY
$63.64 - $125.14 $445,480 - $875,980
7,000 Added 73.49%
16,525 $1.1 Billion
Q2 2024

Aug 13, 2024

BUY
$101.21 - $166.61 $151,815 - $249,915
1,500 Added 18.69%
9,525 $1.13 Billion
Q1 2024

May 15, 2024

BUY
$85.37 - $115.44 $247,573 - $334,776
2,900 Added 56.59%
8,025 $855 Million
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $356,238 - $535,203
5,125 New
5,125 $510 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Inspire Trust Co, N.A. Portfolio

Follow Inspire Trust Co, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Trust Co, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Inspire Trust Co, N.A. with notifications on news.